GNOMGlobal X Genomics & Biotechnology ETF
GNOM Fund Description
GNOM tracks an index of global biotech equities, selected and weighted by market cap.
GNOM Factset Analytics Insight
GNOM is Global X’s take on biotech, with more of an emphasis on genomics specifically. The fund fleshes out its description of this sector by including companies that derive more than 50% of their revenues from the following five business activities: (i) gene editing, (ii) genomic sequencing, (iii) development and testing of genetic medicine/therapies, (iv) computational genomics and genetic diagnostics, and/or (v) biotechnology. The fund uses a proprietary natural language processing algorithm to identify and rank eligible firms based on public documents, such as filings and disclosures. Holdings may span the market-cap spectrum and come from across the globe, including some emerging markets. The market-cap-weighted index is reconstituted and rebalanced semi-annually.
GNOM Summary Data
GNOM Portfolio Data
GNOM Index Data
GNOM Portfolio Management
GNOM Tax Exposures
GNOM Fund Structure
GNOM Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of GNOM. GNOM is rated a 5 out of 5.
GNOM Sector/Industry Breakdown
GNOM Top 10 Holdings[View All]
GNOM Economic Development
GNOM Performance Statistics
GNOM Benchmark Comparison Summary
GNOM Benchmark Comparison Market Cap Size